1. Home
  2. ICFI vs AVLN Comparison

ICFI vs AVLN Comparison

Compare ICFI & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICF International Inc.

ICFI

ICF International Inc.

HOLD

Current Price

$85.99

Market Cap

1.3B

ML Signal

HOLD

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$32.09

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ICFI
AVLN
Founded
1969
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2006
2026

Fundamental Metrics

Financial Performance
Metric
ICFI
AVLN
Price
$85.99
$32.09
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$99.25
N/A
AVG Volume (30 Days)
134.8K
184.1K
Earning Date
05-07-2026
N/A
Dividend Yield
0.82%
N/A
EPS Growth
N/A
N/A
EPS
2.61
N/A
Revenue
$1,229,162,000.00
N/A
Revenue This Year
$4.12
N/A
Revenue Next Year
$5.33
N/A
P/E Ratio
$33.21
N/A
Revenue Growth
3.72
N/A
52 Week Low
$58.83
$24.90
52 Week High
$98.03
$40.17

Technical Indicators

Market Signals
Indicator
ICFI
AVLN
Relative Strength Index (RSI) 46.13 38.65
Support Level $84.61 $25.86
Resistance Level $90.93 $33.32
Average True Range (ATR) 2.29 2.21
MACD -0.50 -0.59
Stochastic Oscillator 33.42 3.40

Price Performance

Historical Comparison
ICFI
AVLN

About ICFI ICF International Inc.

ICF International Inc provides professional services and technology-based solutions, including management, technology and policy consulting and implementation services, to government and commercial clients in the U.S. and internationally. Its government clients include U.S. federal agencies, state and local governments and international governments, as well as commercial clients inside and outside the U.S. It supports clients in Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs; and Security and Other Civilian and Commercial markets. The company delivers services across the life cycle of a policy, program or project through Advisory Services, Program Implementation, Analytics Services, Digital Services and Engagement Services.

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: